Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
0(0%)
Results Posted
17%(1 trials)
Terminated
2(17%)

Phase Distribution

Ph not_applicable
7
58%
Ph phase_3
3
25%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
3(30.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(6)
Terminated(2)
Other(4)

Detailed Status

Completed6
unknown3
Terminated2
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 33 (30.0%)
N/A7 (70.0%)

Trials by Status

unknown325%
suspended18%
terminated217%
completed650%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
PROCEDURE
Total Trials
12